UBS Group’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$727K	Buy	542,905 +248,976	+85%	+$496K	﹤0.01%	5798
2025 Q4	$720K	Buy	293,929 +10,580	+4%	+$45.9K	﹤0.01%	5841
2025 Q3	$1.9M	Sell	283,349 -94,098	-25%	-$614K	﹤0.01%	5000
2025 Q2	$2.22M	Buy	377,447 +16,128	+4%	+$105K	﹤0.01%	4704
2025 Q1	$3.03M	Sell	361,319 -607,115	-63%	-$5.46M	﹤0.01%	4306
2024 Q4	$7.21M	Buy	968,434 +892,456	+1,175%	+$5.97M	﹤0.01%	3422
2024 Q3	$441K	Buy	75,978 +35,959	+90%	+$231K	﹤0.01%	5319
2024 Q2	$266K	Sell	40,019 -44,684	-53%	-$361K	﹤0.01%	5466
2024 Q1	$1.11M	Buy	84,703 +32,904	+64%	+$439K	﹤0.01%	4523
2023 Q4	$660K	Buy	51,799 +51,674	+41,339%	+$522K	﹤0.01%	4853
2023 Q3	$1.64K	Sell	125 -33,199	-100%	-$608K	﹤0.01%	7873
2023 Q2	$852K	Buy	33,324 +19,179	+136%	+$495K	﹤0.01%	4385
2023 Q1	$356K	Buy	14,145 +8,039	+132%	+$189K	﹤0.01%	4952
2022 Q4	$140K	Buy	6,106 +4,664	+323%	+$107K	﹤0.01%	5778
2022 Q3	$32K	Buy	1,442 +637	+79%	+$12.3K	﹤0.01%	6804
2022 Q2	$11K	Buy	805 +705	+705%	+$11.9K	﹤0.01%	7848
2022 Q1	$2K	Sell	100 -9,435	-99%	-$183K	﹤0.01%	9674
2021 Q4	$178K	Buy	9,535 +9,311	+4,157%	+$192K	﹤0.01%	5802
2021 Q3	$6K	Sell	224 -251	-53%	-$6.91K	﹤0.01%	8451
2021 Q2	$15K	Buy	+475	New	+$15.1K	﹤0.01%	7650